Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial
Tuesday, June 8, 2010 - 23:30
in Health & Medicine
A therapy that multiplies the effect of a natural disease-fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial.